Early dosage of statins could cut dementia risk by 15%: Danish study
A recent Danish study reveals that statins could play a role in reducing the risk of dementia among individuals with diabetes. The research analyzed data from more than 132,000 people, indicating that initiating statin therapy soon after a diabetes diagnosis may yield the most significant benefits. While statins are mainly utilized for cardiac health in diabetics, additional studies are necessary…
A Danish study presented at the ESC Congress 2026 found that early initiation of statins after being diagnosed with type 2 diabetes is associated with a lower risk of dementia. Type 2 diabetes and high levels of low-density lipoprotein cholesterol (LDL-C) are both known risk factors for cognitive decline and dementia. Early statin treatment within one year of diabetes diagnosis was linked to a 15% lower relative risk of dementia over 10 years, while late statin initiation between one and five years after diagnosis was associated with a 10% lower risk.
The study, conducted using medical records from Danish registers, followed 132,585 statin-naive patients with type 2 diabetes from 2006 to 2019. The results indicate that statins may be underused in patients with type 2 diabetes, despite their cardiovascular benefits, and suggest that initiating statin treatment soon after a diabetes diagnosis could provide a modest reduction in dementia risk.
However, the observational design of the study does not allow for causal inference, and further research is needed to confirm these findings.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
